Mammoth Private Capital, LLC-Health and Tech Fund Series 4

Series 4 is a special purpose vehicle (SPV) with an objective to pursue a venture capital strategy by investing in a life science company that is working with AI and the development of a machine learning platform and for the purpose of long-term capital appreciation of investments in a specific company meeting that criteria.

Nsight - Mammoth Private Capital, LLC- Health and Tech Fund Series 4

At a Glance

Target Fund Size

$1.5 Million

Success Fee
information
Carried Interest is a share of any profits that the general partners of private equity and hedge funds receive as compensation regardless of whether they contribute any initial funds...

(Carried Interest/Management Fee)

$0

IRA Eligible

No

Admin Fee

$500/year per investor

Minimum

$25,000

Tax Considerations

Reportable Gains

Investment Committee

Documents

Download key information about this fund to review with your trusted financial advisor.

Attachments

PPM
Exhibit A1
Exhibit A2
Certificate of Registered Series
Series Supplement
Exhibit C
Term Sheet
Nsight Surgical, Inc. SAFE
NSight General Risk Factor

About Mammoth

Mammoth Scientific is a venture capital company that specializes in health science and technology funds.

Headquarters

5651 Coventry Lane, Suite 306
Fort Wayne, IN 46804
(800) 618-2299

Tags

  • Atlanta
  • Charleston
  • Charlotte
  • Fort Wayne
  • Metro Detroit


  • Mammoth Scientific is a venture capital company that specializes in health science and technology funds.
  • OFFICE ADDRESS
    3201 Stellhorn Road, Suite A-124
    Fort Wayne, IN 46815

    MAILING ADDRESS
    5651 Coventry Lane, Suite 306
    Fort Wayne, IN 46804
    (800)618-2299
  • OFFICES

    Atlanta
    Charleston
    Charlotte
    Fort Wayne
    Metro Detroit
  • Disclaimer

    The information provided on this mammoth.vc website ("Site") is provided to accredited and qualified investors to assist in evaluating the investment opportunity. The Site itself and the content on the Site are not offering documents. Any offer of securities related to Mammoth Health and Tech Fund 1- Accredited, Mammoth Health and Tech Fund 1- Qualified or any of the Mammoth venture capital funds ("Mammoth Funds") may only be made by Mammoth Scientific, LLC (“Mammoth Scientific”) as the Manager of the Mammoth Funds by delivery of definitive offering documents to the investor. Securities offered by Mammoth Scientific have not been registered under the Securities Act of 1933, as amended or the securities laws of any state or other jurisdictions in reliance upon exemptions from registration provided by the Securities Act and Regulation D Rule 506(c) and comparable exemptions. Mammoth Scientific is an investment advisor to certain venture capital funds and files as an exempt reporting advisor, but that status does not imply a certain level of skill or training.

    PRIVATE COMPANIES AND PRIVATE INVESTMENTS INVOLVE UNIQUE RISKS. YOU SHOULD BE AWARE THAT WHEN INVESTING IN PRIVATE INVESTMENTS, YOU COULD LOSE YOUR ENTIRE INVESTMENT. WE RECOMMEND INVESTORS ONLY INVEST FUNDS WHICH THEY HAVE THE FINANCIAL CAPACITY TO LOSE.

    The Securities Group, LLC (“TSG”) dba Mammoth Research, 3201 Stellhorn Road, Suite A-124, Fort Wayne, IN 46814 is a broker/dealer registered with the Securities and Exchange Commission (“SEC”) and a member of the Financial Regulatory Authority (“FINRA”). In such capacity, TSG is the Managing Placing Agent for the Mammoth Funds. TSG and Mammoth Scientific are under common ownership as subsidiaries of Mammoth Investors, LLC but are not under common control at the day-to-day operating level.

    Investors should always consult the disclosure materials as these materials help investors to understand many of the risks involved with the particular investment which they are considering.

    All product names, logos, and brands are property of their respective owners in the U.S. and other countries and are used for identification purposes only. Use of these names, logos, and brands does not imply affiliation or endorsement.

© 2022, Mammoth Investors, LLC
All rights reserved.
We use cookies to give you the best experience.